The average one-year price target for Atossa Therapeutics (NASDAQ:ATOS) has been revised to 5.36 / share. This is an increase of 13.51% from the prior estimate of 4.72 dated August 1, 2023. The price ...
If you’re on the fence about Atos stock right now, you’re certainly not alone. Watching its price jump by 10.9% in just the past week and an eye-catching 18.4% in the last month, it’s impossible to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback